Triiodothyronine-induced thyrotoxicosis in ophthalmic Graves disease.
A euthyroid woman with ophthalmic Graves disease developed endogenous hyperthyroidism coincident with T3 suppression test. There is a putative role of liothyronine administration in precipitating or activating hyperthyroidism. Aberrancies in T3 suppression testing in graves disease occur.
D001539:Bendroflumethiazide / Q000627:therapeutic use; D005260:Female; D006111:Graves Disease / Q000503:physiopathology; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced* / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D013960:Thyroid Function Tests / Q000009:adverse effects*; D013961:Thyroid Gland / Q000503:physiopathology; D014284:Triiodothyronine / Q000009:adverse effects
D014284:Triiodothyronine; D001539:Bendroflumethiazide; D011441:Propylthiouracil; D011241:Prednisone